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Summary
Neonatal hypoxic–ischaemic (HI) brain injury resulting in
encephalopathy is a leading cause of morbidity and mor-
tality with no effective treatment. Here we show that
caffeic acid phenethyl ester (CAPE), an active component
of propolis, administered either before or after an HI
insult, signiﬁcantly prevents HI-induced neonatal rat
brain damage in the cortex, hippocampus and thalamus.
In addition to blocking HI-induced caspase 3 activation,
CAPE also inhibits HI-mediated expression of inducible
nitric oxide synthase and caspase 1 in vivo and potently
blocksnitricoxide-inducedneurotoxicityinvitro.Further-
more, CAPE directly inhibits Ca
2+-induced cytochrome c
release from isolated brain mitochondria. Thus, CAPE
induces neuroprotection against HI-induced neuronal
death, possibly by blocking HI-induced inﬂammation
and/or directly inhibiting the HI-induced neuronal
death pathway. CAPE may therefore be a novel effective
therapy for preventing neonatal HI injury.
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Introduction
Hypoxic–ischaemic (HI) encephalopathy in the prenatal and
perinatal periods is a major cause of damage to the fetal and
neonatal brain, resulting in considerable morbidity and mor-
tality (Han et al., 2002; Cowan et al., 2003). This insult to the
nervous system is often associated with clinical syndromes of
neurological disability, such as seizures, intellectual impair-
ment and cerebral palsy. Although systemic and cerebrovas-
cular physiological factors play important roles in the initial
phases of the process, the intrinsic death pathways of speciﬁc
neurons and/or systems may be more important in determin-
ing the ﬁnal pattern of neuronal damage and dysfunction. A
key mechanism which is believed to be responsible for
hypoxic–ischaemic neuronal damage is excitotoxicity, a phe-
nomenon which is caused by overstimulation of excitatory
transmitter receptors, mainly glutamate receptors (Johnston
et al., 2001). When excessively stimulated by elevated
synaptic levels of glutamate and membrane depolarization
associated with ischaemia, channels in these receptors
allow a lethal ﬂood of Ca
2+ and sodium to enter neurons.
In the developing brain, HI insults can trigger prominent
delayed programmed cell death or apoptosis as well as necro-
sis (Cheng et al., 1998). Mitochondria appear to play an
essential role in determining the fate of cells subjected to
HI (Gilland et al., 1998). Disrupted mitochondrial function
during HI can lead to cytochrome c protein release and trig-
gers the activation of caspase 3 and/or other caspase-related
apoptotic pathways (Cheng et al., 1998). Furthermore, cyto-
kines, including interleukin 1b and nitric oxide (NO), are also
involved in HI-induced brain injury (Liu et al., 1999; Peeters-
Scholte et al., 2002). The prominence of both apoptosis and
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 necrosis as well as neuroinﬂammation in neurodegenera-
tion after HI in the immature brain suggests that it will be
important to better understand the roles and relationships of
these processes to develop effective neuroprotective strat-
egies. In this study, we used the well-characterized Levine
model (unilateral carotid ligation followed by exposure to
hypoxia), in which features of both apoptosis and necrosis
are prominent for this model in neonatal rats and mice
(Vanucci et al., 1990; Han et al., 2001). Inhibition of
caspase 3 partially protects against brain injury after neonatal
HI injury (Han et al., 2002; Le et al., 2002). These data
suggest that activation of apoptosis-executing caspase 3
plays an important role in neonatal HI injury. Furthermore,
HI-induced activation of proapoptotic pathways may also be
linked to activation of caspase 1 (Peeters-Scholte et al., 2002)
and iNOS (Liu et al., 1999). Most recently, minocycline has
been shown to provide dramatic neuroprotection in this
model,suggestingthatacompoundwhichcaninhibitmultiple
apoptotic targets involved in HI injury may provide a better
therapeutic effect than speciﬁc inhibitors.
Caffeic acid phenethyl ester (CAPE), an antioxidant ﬂavo-
noid, is the active component of the propolis puriﬁed from the
hives of honeybees. It has antiviral, anti-inﬂammatory, anti-
oxidant andimmunomodulatoryproperties(Grunbergeretal.,
1988; Su et al., 1991, 1994). It has been demonstrated that
CAPE is a potent and speciﬁc inhibitor suppressing NF-kB
activation (Natarajan etal.,1996),lipid peroxidation (Sud’ina
et al., 1993), lipoxygenase activities (Laranjinha et al., 1995),
protein tyrosine kinase (Kimura et al., 1985) and ornithine
decarboxylase (Zheng et al., 1995). Most recently, it has been
demonstrated that CAPE is able to block ischaemia- and low
potassium-induced neuronal death (Amodio et al., 2003;
Irmak et al., 2003). We now report that administration of
CAPE effectively blocks HI-induced degeneration of neurons
in the cortex, hippocampus and thalamus. In a mechanistic
study, we have found that CAPE treatment also inhibits
HI-mediated iNOS and caspase 1 expression in vivo and
potently blocks NO-induced neurotoxicity in vitro. Addition-
ally, CAPE is able to protect isolated mitochondria against
Ca
2+-inducedcytochromecreleaseandHI-inducedcaspase3
activation. Thus, both indirect (block HI-induced inﬂamma-
tion) and/or direct inhibition of HI-mediated neurotoxicity
may underlie CAPE’s neuroprotective properties.
Material and methods
Animals and treatment
HI brain damage was induced as described previously (Han et al.,
2002). All animal procedures were approved by the Indiana
University animal committee. Brieﬂy, 7-day-old Sprague–Dawley
rat pups (Harlan Laboratories, Indianapolis, IN, USA) were anaes-
thetized with 2.5% halothane and the left carotid artery was perma-
nently ligated.After surgery, the rat pups were allowed to recoverfor
2 h with their dams. Hypoxic exposure was then achieved by placing
pups in a 2.0-litre airtight plastic chamber submerged in a 37.0C
water bath and ﬂushed for 2.5 h with a humidiﬁed mixture of 8%
oxygen and 92% nitrogen. Pups were then returned to their dams and
housed under a 12-h light and 12-h dark cycle with food and water
until they were killed. Pups (5–7 per group) received intraperitoneal
injections of CAPE (40 mg/kg/day) dissolved in corn oil or vehicle
before and/or after the hypoxic insult.
Tissue preparation and assessment of brain
infarct volume
Following treatment, rats were anaesthetized by halothane inhalation
and perfusion-ﬁxed with 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4). After postﬁxation and cryoprotection in 30%
sucrose/phosphate buffer, brains were frozen in liquid nitrogen
and sectioned serially (50 mm). Coronal sections from the genu of
the corpus callosum to the end of the dorsal hippocampus were
stained with cresyl violet as described previously (Han et al.,
2002). For Western blotting and caspase 3 activity assay, some
rats were decapitated and each side of the cerebral cortex and hip-
pocampus was dissected on a dryice-cooled glass plate. After adding
1.5 ml of buffer (0.1 M potassium phosphate, pH 7.5, 20 mM
ethylenediamine tetraacetate (EDTA), the tissue was homogenized
in ice. The supernatant was obtained by centrifugation (14 000 r.p.m.
for 20 min). To determine infarct volume, brieﬂy, the cross-sectional
areas of the cortex, hippocampus and thalamus in each of eight
equally spaced reference planes were photo-scanned, and the area
of each brain region was calculated using the SPOT software
(Diagnostic Instrument, VA, USA). The sections used for quantiﬁca-
tion corresponded approximately to plates 12, 15, 17, 20, 23, 28, 31
and34intheratbrainatlas(Hanetal.,2002).Thepercentagevolume
occupied by HI damage in the cortex and the hippocampus was
obtained by dividing the sum of the damaged areas ipsilateral to
the carotid ligation (left side) by the sum of the ipsilateral areas
of the corresponding normal area (right side). For statistical analysis,
one-way analysis of variance (ANOVA) was used tocompare groups
with a p < 0.05 signiﬁcance cut-off.
Primary rat CGN neuronal cultures and
neurotoxicity assays
Cerebellar granule neurons (CGN) were prepared from 8-day-old
Sprague–Dawley rat pups (Harlan Laboratories) as described pre-
viously (Du et al., 1997). Brieﬂy, freshly dissected cerebella were
dissociated and the cells were seeded at a density of 1.2 to 1.5 3
10
6 cells/ml on poly-L-lysine-coated dishes in basal medium Eagle
supplemented with 10% fetal bovine serum, 25 mM KCl and genta-
micin (0.1 mg/ml). Cytosine arabinoside (10 mM) was added to the
culture medium 24 h after initial plating. All experiments used neu-
rons after 7–8 days in vitro. Viable neurons were quantiﬁed by
counting ﬂuorescein-positive (green) cells, which result from the
de-esteriﬁcation of ﬂuorescein diacetate by living cells. Brieﬂy, cul-
tures were incubated with ﬂuorescein diacetate (10 mg/ml) for 5 min
and examined and photographed using UV light microscopy, and the
numbers of neurons from representative low-power ﬁelds were
counted as described previously (Du et al., 1997). Propidium iodide,
which interacts with nuclear DNA to produce a red ﬂuorescence, was
used to identify dead neurons. For propidium iodide staining, cul-
tureswereincubatedwithpropidiumiodide(5mg/ml),examined,and
photographed using UV light microscopy as described previously
(Du et al., 1997).
Caspase 3 activity assay (Du et al., 1997)
Brain tissues were collected and homogenized with 20 strokes
of a B-type pestle in precooled buffer (50 mM Tris–HC1 pH 7.4,
2630 X. Wei et al.
b
y
 
g
u
e
s
t
 
o
n
 
N
o
v
e
m
b
e
r
 
3
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 1 mM EDTA, 10 mM ethyleneglycol-bis-(b-aminoethylether)-N,
N-tetraacetic acid (EGTA), 1mM dithiothreitol (DTT), 0.1 mM
phenylmethylsulfonyl ﬂuoride (PMSF), 2 mg/ml aprotinin). Lysates
were centrifuged at 15 000 r.p.m. at 4C for 20 min and protein
concentrations were determined (Pierce, Rockford, IL, USA) (Du
et al., 1997). Extracts were either used immediately or stored at
80C. Aliquots of protein (30 mg) were incubated with 100 mM
caspase 3 substrate (Ac-DEVD-pNA; Calbiochem, La Jolla, CA,
USA) in a total volume of 1.0 ml at 37C. The colorimetric release
of p-nitroaniline from the Ac-DEVD-pNA substrate was recorded at
60 min and 405 nm. Enzymatic activity for caspase 3 was linear over
the range ofprotein concentrations usedto calculate speciﬁc activity.
Western blot analysis
Western blot analysis was performed on rat brain extracts from
selected regions and cell cytoplasmic extracts. Extracts were pre-
pared by lysing tissues/cells in a buffer containing 1% Nonidet P-40,
0.1% sodium dodecyl sulphate (SDS), 50 mM Tris (pH 8.0), 50 mM
NaC1, 0.05% deoxycholate and protease inhibitor (Roche,
Indianapolis, IN, USA). Proteins (10 mg) were size-fractionated
on a 4–12% polyacrylamide gradient gel (SDS-NuPAGE) and trans-
ferred onto nitrocellulose (Hybond N; Amersham, CA, USA). Blots
were then probed with polyclonal or monoclonal antibodies, fol-
lowed by a secondary antibody conjugated with horseradish peroxi-
dase (Jackson ImmunoResearch Laboratories, PA, USA) and
visualized using enhanced chemiluminescence.
Mitochondrial isolation and cytochrome c assay
Rat brain and liver mitochondria were prepared from 7-day-old
Sprague–Dawley rats. Brieﬂy, brains and livers were homogenized
in ice-cold buffer containing 250 mM mannitol, 75 mM sucrose and
10 mM K-HEPES (pH 7.4), and homogenates were centrifuged at
1000gfor10min.Supernatantswerethencentrifugedat10000gfor
15 min. Pellets that were washed three times were used immediately
inexperiments.Forinvitrocytochromecassay,analiquot of12.5mg
liver and brain mitochondria (25 ml) was pretreated with CAPE for
5 min following challenge with 100 mM of CaCl2 for 30 min at 30C.
After centrifugation, the supernatant was evaluated by western blot-
ting. To assay neuronal cytochrome c release, CGN were washed
once with ice-cold phosphate-buffered saline and harvested in 500 ml
ice-cold buffer A (50 mM Tris–HCl, pH 7.4; 1 mM EDTA; 1 mM
DTT; complete protease inhibitor (Roche); 250 mM sucrose). The
cells were disrupted by douncing 10 times with a pestle in a 7-ml
Wheatondouncer.Aftercentrifugationinamicrocentrifugeat1000g
for 10 min at 4C, the supernatants were further centrifuged at
12000 g for 40 min. The resulting supernatants were used for
immunoblot analysis.
Results
CAPE markedly attenuates HI-induced brain
damage
To investigate the neuroprotective effects of CAPE on
HI-induced neuronal death in vivo, we treated 7-day-old
rats with CAPE (40 mg/kg intraperitoneally) or solvent (con-
trol) once a day for 7 days. Rats were exposed to HI injury
30 min after the ﬁrst drug treatment. Seven days after HI
injury, the brains were analysed histologically to quantify
the amount of damage in the cortex, hippocampus and tha-
lamus (Han et al., 2002). HI injury resulted in approximately
41, 54 and 32% of tissue loss in the cortex, hippocampus and
thalamus, respectively, compared with non-injured controls
(p < 0.001) (Fig. 1A and B). Rats that received CAPE showed
signiﬁcantly reduced tissue damage in these areas compared
with solvent-treated animals (cortex, 26% damage, p < 0.001;
hippocampus, 19% damage, p < 0.001; thalamus, 14%
damage, p < 0.001) (Fig. 1A and B). In contrast, we found
no evidence ofbrain injuryin sham-operated animals exposed
only to hypoxia (data not shown).
Wenext treatedanimals with CAPE(40 mg/kg,intraperito-
neally)4hafteranHIinsulthadbeencompleted.Interestingly,
CAPE treatment signiﬁcantly protected neurons against
HI-induced neuronal death in the cortex and hippocampus
even when given 4 h after HI insult. Rats that received CAPE
4 h after an HI insult showed a signiﬁcantly greater volume of
remaining tissue in the cortex and hippocampus than solvent-
treatedrats(cortex,51versus66%,p<0.001;hippocampus,40
versus66%,p<0.001)(Fig.1C).CAPEtreatments4hafterHI
injury also exerted a neuroprotective effect in the thalamus,
although not signiﬁcantly (64 versus 75%) (Fig. 1C).
The neuroprotective effects of CAPE observed in our
experiments could not be attributed to hypothermia because
the temperature of animals treated with CAPE for 60 min did
not differ from that of animals treated with vehicle (vehicle,
36.2 6 0.2C; CAPE, 36.6 6 0.6C, eight animals per group,
p > 0.05).
CAPE pretreatments attenuate HI-induced
caspase 3 activation
The underlying cellular mechanisms by which CAPE induces
neuroprotection in the neonatal HI model remain unclear.
Previous studies have shown that HI-induced neuronal
death has features of apoptosis (Hill et al., 1995) with prom-
inent caspase 3 activation (Cheng et al., 1998; Liu et al.,
1999). Therefore, we asked whether CAPE pretreatment
blocks HI-induced caspase 3 activity in the neonatal brain.
In brain lysates derived from animals treated with CAPE, no
induction of caspase 3 activity was detected in the ipsilateral
cortex, which was subjected to HI treatments. In contrast,
consistent with previous reports, lysates from animals treated
with vehicle showed markedly increased caspase 3 activity in
the cortex ipsilateral to carotid ligation. CAPE pretreatments
signiﬁcantlyblockedHI-inducedcaspase3activation (Fig.2).
CAPE blocks Ca
2+-induced cytochrome
c release
Since both intracellular Ca
2+ overload (Delivoria-
Papadopoulos and Mishra, 2000) and caspase 3 activation
play important roles in HI-induced neurotoxicity, we exam-
ined Ca
2+-induced release of cytochrome c, an apoptotic
initiator which directly activates caspase 3, to investigate
the primary target of CAPE. As shown in Fig. 3, 100 mM
Ca
2+wasabletoinducecytochromecreleasefrommitochon-
dria isolated from neonatal rat brains, and CAPE signiﬁcantly
blockedCa
2+-inducedcytochromecreleasestartingat20mM,
Caffeic acid phenethyl ester prevents neonatal hypoxic–ischaemic brain injury 2631
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 which is a concentration 10 times lower than that producing a
similar effect with minocycline (Zhu et al., 2002). A similar
result has been observed in experiments using liver
mitochondria.
CAPE pretreatments markedly attenuate
HI-induced iNOS and caspase 1 overexpression,
as well as NO-induced neurotoxicity
SinceNOsynthasesandcaspase1havebeenproposedtomediate
(at least in part) HI-induced neuronal death (Liu et al., 1999;
Peeters-Scholte et al., 2002), we measured both iNOS and
caspase 1 in hippocampal homogenates of rats treated with
HI (Fig. 4). Twenty four hours after HI treatment, both
iNOS and caspase 1 were upregulated in hippocampal homo-
genates, as determined by western blotting. This increase was
partially blocked by pretreatment with CAPE (Fig. 4). In con-
trast, neither HI injury nor CAPE had any effect on nNOS
expression in these same samples (Fig. 4). Furthermore,
since NO has been shown to play an important role in
HI-induced neurotoxicity (Peeters-Scholte et al., 2002), we
went on to determine whether CAPE affected NO-mediated
injury. We asked whether CAPE could directly block
NO-induced neurotoxicity in cultured neurons. Treatment of
CGN with the NO donor sodium nitroprusside resulted in sig-
niﬁcant neuronal death in CGN. This cell death was almost
completely blocked by CAPE at 10 mM (Fig. 5).
Discussion
The results in this report provide the ﬁrst evidence, to our
knowledge, that CAPE given before or 4 h after a neonatal HI
insult can effectively protect against neuronal and tissue loss
in the cortex, hippocampus and thalamus in vivo. The ﬁnding
is in agreement with previous studies showing that CAPE
protects against ischaemia–reperfusion injury of the spinal
cord (Ilhan et al., 1999) and brain (Irmak et al., 2003).
Prior studies suggest that caspase 3 is the important factor
contributing to delayed caspase-dependent cell death after
neonatal HI. Caspase 3 inhibitors block caspase 3 activation
and cleavage of its substrates, resulting in signiﬁcant neuro-
protection against HI-induced brain injury. These results are
in line with our ﬁnding that HI-induced caspase 3 activation is
inhibited by CAPE. Since CAPE does not directly inhibit
caspase 3 enzyme activity (data not shown), we decided to
evaluate its effect on cytochrome c release as cytochrome
released from mitochondria is a potent stimulus for caspase
3 activation (Liu et al., 1996). Our results clearly demonstrate
that inhibition of cytochrome c release is one of the primary
targets of CAPE. Given that the concentration required for the
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Fig. 1 CAPE prevents neuronal loss after hypoxic–ischaemic
injury. (A) Representative coronal sections of postnatal day 14
(P14) rat brains demonstrate that 7 days after unilateral (left)
carotid ligation and exposure to hypoxia for 2.5 h at P7 (see Han
et al., 2002 for details) with or without treatment with CAPE at 40
mg/kg daily. (a) Untreated. (b) Ischaemia treated with corn oil. (c)
Ischaemia treated after 0.5 h of pretreatment with CAPE at
40 mg/kg. Note the moderate or severe damage in the hemisphere
ipsilateral to carotid ligation in most animals (compare a with b)
and the signiﬁcant protection by CAPE (compare b with c).
Arrows indicate lesioned sides. (B, C) Assessment of brain infarct
tissue loss in the cortex, hippocampus and thalamus was carried
out as described in the text. The area of tissue in the hippocampus
ipsilateral to the lesioned hemisphere was compared in the same
animal with the area of tissue remaining in the matching brain
region contralateral to the unlesioned hemisphere. The percentage
area loss was then determined in each animal, and data are
presented as the mean 6 SEM for each group. (B) CAPE at 40
mg/kg 0.5 h before hypoxia signiﬁcantly protects against volume
losses of cortex, hippocampus and thalamus induced by ischaemic
injury (59 6 2 versus 84 6 3, 46 6 3 versus 81 6 5, and 68 6 3
versus 86 6 2, respectively; n = 13, one-way ANOVA,
***p < 0.001). (C) CAPE at 40 mg/kg 4 h after hypoxia also
protects against HI-induced volume losses in cortex, hippocampus
and thalamus (51 6 4 versus 66 6 4, 40 6 4 versus 66 6 5,
and 64 6 5 versus 75 6 3, respectively; n = 8 mice/group,
one-way ANOVA, ***p < 0.001) (see text for details).
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 inhibition of cytochrome c release may start at 20 mM, far less
than the required minocycline concentration (200 mM; Zhu
et al., 2002), these data suggest that CAPE might be a potent
agent protecting mitochondria. Furthermore, according to the
analysesofZhuandcolleagues,theconcentrationsrequiredof
minocycline and CAPE have both been overstated, since very
high concentrations of isolated mitochondria have been used
in experiments. The physiologically relevant concentrations
of CAPE may be at least 100 times less than those used in
experiments (0.2 mM), according to the adjustments of Zhu
and colleagues. How much CAPE is really required to protect
mitochondria from the release of cytochrome c in the physio-
logical conditions, however, remains to be determined.
Additionally, CAPE treatment reduced the induction of
caspase 1 to 38% when estimated by western blotting 24 h
after HI treatments. Caspase 1 cleaves inactive precursor,
prointerleukin-1b (pro-IL-1b) to the mature form of IL-1b,
which is a proinﬂammatory cytokine (Yrjanheikki et al.,
1998). Mice deﬁcient in caspase 1 are resistant to neonatal
hypoxic–ischaemic brain damage (Xu et al., 2001), suggest-
ing that inhibition of caspase 1 induction contributes to
neuroprotection by CAPE treatment.
In the HI model, it is also suggested that neuronal nitric
oxide synthase (nNOS) and iNOS correlate with neurotoxic
effect by release of NO under uncontrolled circumstances,
whereasendothelialnitricoxidesynthase(eNOS)hasaneuro-
protective effect (Bolanos and Almeida, 1999). Inhibitors of
these two forms of NOS protect against HI-induced brain
damage (Peeters-Scholte et al., 2002). Interestingly, in addi-
tion to reducing iNOS induction, we demonstrate that CAPE
treatment can directly block NO-induced neuronal death, sug-
gesting that the neuroprotective effects of CAPE may also be
related to the ability of CAPE to directly inhibit iNOS expres-
sion and NO-mediated neuronal death. Inhibition of iNOS by
CAPE may be able to directly or indirectly prevent mitochon-
driadamageandtheresultingneuronaldeathbyattenuationof
ATP depletion, glutamate release and the formation of
reactive derivatives such as peroxynitrite, NO2,N 2O3 and
S-nitrosothiols (Brown and Bal-Price, 2003).
In this study, however, we cannot rule out CAPE, as an NF-
kB inhibitor may inhibit NF-kB-induced neurotoxicity in
ischaemic injury, as suggested by several reports (Schneider
et al., 1999; Nurmi et al., 2004), although the exact role of
NF-kB in the regulation of neuronal death in HI-induced
injury remains unclear (Lipton, 1997; Matsushita et al.,
2003). Blockade of NF-kB activation by CAPE may provide
additive neuroprotection against neonatal HI. However, it has
been reported that NF-kB in the same neurons behaves as a
stimulus-dependent, anti-apoptotic or pro-apoptotic factor
(Kaltschmidt et al., 2002), so further investigation is required
to conﬁrm the role of NF-kB in CAPE-induced neuroprotec-
tion on neonatal HI models. Since both iNOS and caspase 1
have been reported to be involved in ischaemic injury, our
data suggest that the anti-inﬂammatory effects of CAPE may
actbysynergic neuroprotectiontogetherwith a‘direct’neuro-
protective action on neurons to protect the brain against brain
injury. Furthermore, since inﬂammation, the release of cyto-
chrome c and caspase 3 activation are shared features for a
variety of neurodegenerative disorders, inhibition of these
factors simultaneously by CAPE may contribute to the
CAPE (µM) 0 20 100 200
Cytochrome c
A
B
0
20
40
60
80
100
120
0 20 100 200
C
y
t
o
c
h
r
o
m
e
 
c
 
(
A
r
b
i
t
r
a
r
y
 
U
n
i
t
s
)
***
*** ***
Fig. 3 CAPE blocks Ca
2+-induced cytochrome c release. (A) Rat
brain mitochondria were treated with CaCl2 (100 mM) in the
presence or absence of CAPE for 30 min and cytochrome c release
was evaluated by western blotting. (B) Densitometric
quantiﬁcations of cytochrome c release were compared between
CAPE-treated and untreated samples (n = 3/group, *p < 0.05).
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Fig. 2 CAPE pretreatments attenuate HI-induced caspase 3
activation in vivo. The caspase 3-speciﬁc colour substrate
Ac-DEVD-pNA was incubated for 60 min at 37C with protein
extracts (30 mg) collected from the cortex treated with HI in the
presence or absence of CAPE (40 mg/kg) for 24 h. Measurements
were taken at 405 nm (see Material and methods for details).
Caspase 3 protease activity was markedly induced 24 h after
HI treatments, and was signiﬁcantly attenuated with CAPE
pretreatments (one-way ANOVA, ***p < 0.001).
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 broad spectrum of effects of this drug in the inhibition of
neuronal death. However, before CAPE becomes a novel
effective therapy for preventing neonatal HI injury, further
studies on its ability to cross the blood–brain barrier and its
human safety are required.
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Fig. 5 CAPE signiﬁcantly inhibits NO-induced CGN neuronal
death. CGN were exposed to CAPE (10 mM) for 24 h in the
presence or absence of sodium nitroprusside (SNP; 50 mM;
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visual counting of viable neurons from representative
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Fig. 4 CAPE pretreatments block HI-induced iNOS and caspase 1 expression in vivo. Immunoblot analyses were performed with polyclonal
antibodies against iNOS, nNOS and caspase 1 (Santa Cruz). Ischaemia treatment increases iNOS and caspase 1 expression by 24 h
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to alter nNOS expression in these same samples. C = control. Group data (n = 3) on protein levels of caspase 1 and iNOS were
normalized for nNOS.
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